|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accrued revenue and accounts receivable | ||||||||||||||||||||
| Commodity derivative assets, net | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| TOTAL CURRENT ASSETS | ||||||||||||||||||||
| PROPERTY AND EQUIPMENT | ||||||||||||||||||||
| Oil and natural gas properties, at cost, using the successful efforts method of accounting, includes unproved properties of $1,099,220 and $1,063,709 at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Accumulated depreciation, depletion, amortization and impairment | ||||||||||||||||||||
| Oil and natural gas properties, net | ||||||||||||||||||||
| Other property and equipment, net of accumulated depreciation of $16,229 and $15,768 at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| NET PROPERTY AND EQUIPMENT | ||||||||||||||||||||
| DEFERRED CHARGES AND OTHER LONG-TERM ASSETS | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES, MEZZANINE EQUITY, AND EQUITY | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Commodity derivative liabilities, net | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| TOTAL CURRENT LIABILITIES | ||||||||||||||||||||
| LONG–TERM LIABILITIES | ||||||||||||||||||||
| Credit facility | ||||||||||||||||||||
| Accrued incentive compensation | ||||||||||||||||||||
| Commodity derivative liabilities, net | ||||||||||||||||||||
| Asset retirement obligations | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| MEZZANINE EQUITY | ||||||||||||||||||||
| Partners' equity – Series B cumulative convertible preferred units, 14,711 units outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| EQUITY | ||||||||||||||||||||
| Partners' equity – general partner interest | ||||||||||||||||||||
| Partners' equity – common units, 212,703 and 211,873 units outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| TOTAL EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES, MEZZANINE EQUITY, AND EQUITY |
Loading...
